---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-26-060232"
form_type: "8-K"
ticker: "MNOV"
cik: "0001226616"
company_name: "MEDICINOVA INC"
filed_at: "2026-02-20T23:59:59+00:00"
generated_at: "2026-05-16T01:24:28.945536+00:00"
event_type: "earnings"
sentiment: "negative"
materiality_score: 0.65
calibrated_materiality_score: 0.65
confidence: "high"
source: SEC EDGAR
---

# MediciNova FY2025 net loss per share $0.24, operating loss $13.3M, cash down to $30.8M

## Summary
- Net loss attributable to shareholders $12.0M ($0.24 per share) vs $11.0M ($0.23) in FY2024.
- Operating loss widened to $13.3M from $12.7M; net sales (collaboration revenue) totaled $0.41M.
- Cash and equivalents fell to $30.8M from $40.4M; shareholders' equity decreased to $41.6M.
- No dividend paid; FY2026 guidance withheld due to uncertainty around out-licensing activities.

## SEC filing metadata
- accession: 0001193125-26-060232
- form_type: 8-K
- ticker: MNOV
- cik: 0001226616
- company_name: MEDICINOVA INC
- filed_at: 2026-02-20T23:59:59+00:00
- event_type: earnings
- sentiment: negative
- materiality_score: 0.65
- calibrated_materiality_score: 0.65
- confidence: high
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1226616/000119312526060232/0001193125-26-060232-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1226616/000119312526060232/d101814d8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-26-060232
- JSON: https://secwatch.observer/filing/0001193125-26-060232.json
- Plain text: https://secwatch.observer/filing/0001193125-26-060232.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.